Stocklytics Platform
Asset logo for symbol UTMD
Utah Medical Products
UTMD55
$53.83arrow_drop_up0.95%$0.50
Asset logo for symbol UTMD
UTMD55

$53.83

arrow_drop_up0.95%
Key Stats
Open$53.32
Prev. Close$53.32
EPS3.96
Next Earnings DateJul 2, 2025
Market Cap$178.16M
LOWHIGH
Day Range53.10
54.42
52 Week Range51.28
87.99
Ratios
EPS3.96
Fundamentals
Industry average yield2.89%
Last Dividend pay dateApr 3, 2025

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

UTMD-
US Healthcare Sector-
US Market-
check_circle

UTMD / Market

UTMD exceeded the US Market which returned -0.39% over the last twenty four hours.
warning

UTMD / Healthcare Sector

UTMD lose to the US Healthcare sector which returned 2.22% over the last twenty four hours.

Utah Medical Products (UTMD) Statistics

Utah Medical Products Inc (UTMD) is a company that specializes in the design, manufacturing, and distribution of medical devices for the healthcare industry. The company is based in Utah and has been in operation for over 40 years. UTMD stock has shown strong performance in recent years, consistently outperforming the sector average. The stock has a strong valuation, with a high price-to-earnings (P/E) ratio and a low price-to-sales (P/S) ratio. The company's fundamentals are also solid, with a healthy profit margin and low levels of debt. UTMD's revenue per share is impressive, indicating strong sales growth. The Enterprise to EBITDA ratio, a measure of a company's operating performance, is also favorable, indicating that UTMD is generating strong profits from its operations.
The CEO of Utah Medical Products Inc is John L. Banks. Under his leadership, the company has seen significant growth and success. Banks has a strong background in the healthcare industry and is known for his strategic vision and ability to lead teams to achieve exceptional results. He has been instrumental in driving UTMD's innovation and expanding its product portfolio. With his guidance, the company has been able to stay ahead of market trends and maintain its competitive edge. Banks is committed to delivering high-quality medical devices that improve patient outcomes and enhance healthcare professionals' ability to provide excellent care. Under his leadership, UTMD has become a trusted name in the healthcare industry and continues to be a leader in the medical device market.
add Utah Medical Products  to watchlist

Keep an eye on Utah Medical Products

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Utah Medical Products (UTMD) stock's performance compared to its sector and the market over the past year?

Over the past year, Utah Medical Products (UTMD) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 15.17%, Utah Medical Products has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 23.68%, it has fallen short of the market average. This comparison highlights Utah Medical Products 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Utah Medical Products (UTMD) stock?

The PE (Price to Earnings) ratio of Utah Medical Products (UTMD) is currently 13.59. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of Utah Medical Products (UTMD) stock?

The Earnings Per Share (EPS) for Utah Medical Products (UTMD), calculated on a diluted basis, is $3.96. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Utah Medical Products (UTMD) stock?

The operating margin for Utah Medical Products (UTMD) is 35.56%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Utah Medical Products (UTMD) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Utah Medical Products (UTMD) is $19.25M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Utah Medical Products (UTMD) have?

Utah Medical Products (UTMD) has a total debt of $282K. The net debt, which accounts for cash and cash equivalents against the total debt, is -$88.15M.

Take Your Investments to a Whole New Level